What is the brand name for Cefpodoxime (Cefpodoxime proxetil)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Cefpodoxime is available under several brand names, with Vantin being the most common in the United States, as well as Banan in Japan and Orelox in various European countries.

Key Points

  • Cefpodoxime is a third-generation cephalosporin antibiotic that comes in oral form, typically as cefpodoxime proxetil, which is a prodrug that converts to the active form in the body 1.
  • It's commonly prescribed at doses of 100-400 mg twice daily, depending on the infection being treated, with typical treatment durations of 5-14 days.
  • The medication works by inhibiting bacterial cell wall synthesis, making it effective against many gram-positive and gram-negative bacteria.
  • Patients should take cefpodoxime with food to enhance absorption and should complete the full course of treatment even if symptoms improve before finishing the prescription.
  • Those with penicillin allergies should inform their healthcare provider before taking cefpodoxime, as there is potential for cross-reactivity between cephalosporins and penicillins.

Important Considerations

  • Cefpodoxime proxetil has been ranked as having a predicted clinical efficacy of 83% to 88% for adults with acute bacterial rhinosinusitis, according to the study published in Otolaryngology--head and neck surgery 1.
  • The study also recommends cefpodoxime proxetil as an initial therapy option for adult patients with mild disease who have not received antibiotics in the previous 4 to 6 weeks 1.

From the FDA Drug Label

Cefpodoxime proxetil tablets, USP contain cefpodoxime proxetil equivalent to 100 mg or 200 mg of cefpodoxime activity Cefpodoxime Proxetil Tablets, USP 200 mg* Rx only 100 Tablets SANDOZ

The brand name for cefpodoxime is not explicitly stated in the provided drug labels, but Sandoz is mentioned as the manufacturer of Cefpodoxime Proxetil Tablets, USP 2. However, it is unclear if Sandoz is the brand name or just the manufacturer.

  • Key points:
    • Cefpodoxime is the active metabolite of cefpodoxime proxetil 2
    • Sandoz is the manufacturer of Cefpodoxime Proxetil Tablets, USP 2

From the Research

Cefpodoxime Brand Name

  • The studies provided do not mention a specific brand name for cefpodoxime 3, 4, 5, 6.
  • However, it is mentioned that cefpodoxime is available as a prodrug called cefpodoxime proxetil, which is absorbed readily from the gut 3.
  • Cefpodoxime proxetil is an oral third-generation cephalosporin with a broad spectrum of antibacterial activity 4.

Uses of Cefpodoxime

  • Cefpodoxime is used to treat various bacterial infections, including upper and lower respiratory tract infections, sinusitis, otitis media, skin and soft tissue infections, and urinary tract infections 3, 4, 5.
  • It is also used as an alternative to levofloxacin for antibiotic prophylaxis in allogeneic stem cell transplant patients 6.

Efficacy of Cefpodoxime

  • Cefpodoxime has been shown to be effective in treating various bacterial infections, with clinical efficacy rates similar to those of other antibiotics such as amoxicillin/clavulanic acid, cefixime, and cefuroxime axetil 4, 5.
  • It has also been shown to be effective in preventing antibiotic prophylaxis failure in allogeneic stem cell transplant patients, with similar rates of neutropenic fever and antibiotic prophylaxis failure compared to levofloxacin 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Cefpodoxime: pharmacokinetics and therapeutic uses.

Indian journal of pediatrics, 2003

Research

Clinical efficacy of cefpodoxime in respiratory tract infection.

The Journal of antimicrobial chemotherapy, 2002

Research

Levofloxacin versus Cefpodoxime for Antibacterial Prophylaxis in Allogeneic Stem Cell Transplantation.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.